Filters: Author is Helfand, S C [Clear All Filters]
.
2005. Aberrant p53 expression in feline vaccine-associated sarcomas and correlation with prognosis.. Veterinary pathology. 42(6):805-11. Abstract
.
1995. Acute effects of continuous infusions of human recombinant interleukin-2 on serum thyroid hormone concentrations in dogs.. Research in veterinary science. 58(1):96-7. Abstract
.
1995. Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin.. Clinical cancer research : an official journal of the American Association for Cancer Research. 1(12):1595-601. Abstract
.
2006. Biological and molecular characterization of a canine hemangiosarcoma-derived cell line.. Research in veterinary science. 81(1):76-86. Abstract
.
2004. Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium.. Laboratory investigation; a journal of technical methods and pathology. 84(5):562-72. Abstract
.
1993. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide.. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine. 7(6):370-6. Abstract
.
1994. Clinical and immunological effects of human recombinant interleukin-2 given by repetitive weekly infusion to normal dogs.. Cancer immunology, immunotherapy : CII. 39(2):84-92. Abstract
.
1990. Clinical management of the cancer patient. Principles and applications of chemotherapy.. The Veterinary clinics of North America. Small animal practice. 20(4):987-1013. Abstract
.
2009. Diagnostic exercise: epithelioid hemangiosarcoma mimicking metastatic prostatic neoplasia in a dog.. Veterinary pathology. 46(3):548-52. Abstract
.
2004. Enhancement of the antiangiogenic activity of interleukin-12 by peptide targeted delivery of the cytokine to alphavbeta3 integrin.. Molecular cancer research : MCR. 2(12):663-73. Abstract
